Immunological effects of autohemo vaccination and autogenous vaccination in bovine with cutaneous papillomatosis virus

Authors

  • Andrés Suárez-Usbeck Escuela Superior Politécnica de Chimborazo - ESPOCH https://orcid.org/0000-0002-6626-8224
  • Pamela Vinueza Escuela Superior Politécnica de Chimborazo - ESPOCH https://orcid.org/0000-0001-5880-1706
  • Marilyn Mora Escuela Superior Politécnica de Chimborazo - ESPOCH
  • Anahí Carrasco Grupo de Investigación Ecuatoriano en Medicina y Sanidad Animal
  • Tirsa Echeverria Grupo de Investigación Ecuatoriano en Medicina y Sanidad Animal
  • Andrea Vela Universidad Técnica de Ambato - UTA https://orcid.org/0000-0002-2557-855X

DOI:

https://doi.org/10.17533/udea.rccp.e355957

Keywords:

autogenous, autohemovaccine, bovine papillomavirus, cattle, IL-6, immunological effects, leucocyte, papillomavirus, PCR, vaccine

Abstract

Papillomavirus is a viral pathogen known to instigate the development of benign tumors in mammalian hosts. Various therapeutic approaches exist for managing cutaneous papilloma resulting from bovine papillomavirus (BPV) Autohemovaccine (AHV), and autogenous vaccine (ATV) stands as one such method. The aim of research was to scrutinize the immunological effects of AHV and ATV in cattle in Ecuador. 150 cattle with symptoms of cutaneous were diagnosed using PCR and distributed among different groups. To create the vaccines, n= 25 were used in AHV protocol with 20 mL and n=25 with 10 mL blood doses administered to them, n= 25 were used in 10 mL and 20 mL in ATV protocol. ATV vaccines were prepared by adding 0.5% formalin to the suspension, which was topped up by crystal penicillin. The vaccines were stored at 4°C until used. Vaccines (AHV & ATV) were administered 4 times subcutaneous at 1-week intervals in 20 and 10 mL dosages, respectively. Hematological and immunological analyses were performed by collecting the blood samples before and after each vaccination. while the remaining subjects (n=50) will serve as positive control group (C+). The findings demonstrated in ATV (10 and 20 mL) and AHV (10 and 20 mL) a notable surge in leukocyte (14.5; 14; 15.4; 16 103/mm3), lymphocyte (55; 52; 58; 62 %), and interleukin-6 (0.85; 0.80; 0.95; 0.97 ng/L), Neutrophil (33; 35; 44; 40%) and Monocyte (5; 8; 12; 13 %) compared with C+ (Leu: 13 103/mm3; Lym: 50 %; IL-6: 0.54 ng/L; Neu: 34%; Mon: 6.5%) . In AHV and ATV, encouragingly, within the first month post-vaccination, signs of regression in cutaneous papilloma became evident. As a conclusion, bovine papillomatosis represents a condition of considerable economic significance within the domain of dairy farming. The study underscores autogenous vaccination as a pragmatic therapeutic intervention, effectively prompting lesion regression, particularly through the stimulation of IL-6 and lymphocyte production in cattle infected with papillomavirus.

|Abstract
= 38 veces | PDF
= 20 veces|

Downloads

Download data is not yet available.

Author Biographies

Andrés Suárez-Usbeck, Escuela Superior Politécnica de Chimborazo - ESPOCH

Chief of Scientific Direction and Research in the field of animal production and health at CCLabs, Ecuador.
Professor at UNAM, Mexico.
LinkedIn Profile: Andrés Suárez Usbeck

Pamela Vinueza, Escuela Superior Politécnica de Chimborazo - ESPOCH

Facultad de Ciencias Pecuarias, ESPOCH, Ecuador.
Grupo de Investigación en Ciencias Veterinarias (GICV), ESPOCH, Ecuador.

Marilyn Mora, Escuela Superior Politécnica de Chimborazo - ESPOCH

Facultad de Ciencias Pecuarias, ESPOCH, Ecuador

Anahí Carrasco, Grupo de Investigación Ecuatoriano en Medicina y Sanidad Animal

Grupo de Investigación Ecuatoriano en Medicina y Sanidad Animal (GIEMSA, IIEMSA), Ecuador.

Tirsa Echeverria, Grupo de Investigación Ecuatoriano en Medicina y Sanidad Animal

Grupo de Investigación Ecuatoriano en Medicina y Sanidad Animal (GIEMSA, IIEMSA), Ecuador

Andrea Vela, Universidad Técnica de Ambato - UTA

Universidad Técnica de Ambato, UTA, Ecuador

References

Aksoy P, Gottschalk EY, Meneses PI. HPV entry into cells. Mutat Res Rev Mutat Res 2017; 772:13-22. doi: 10.1016/j.mrrev.2016.09.004

Alcigir ME, Atalay Vural S, Timurkan MO. Investigation of E2, E5 and E6 gene expression and DNA in situ fragmentation findings associated with progressive and regressive changes in benign neoplastic cutaneous lesions arising naturally from bovine papillomavirus-1 infection. Medycyna Weterynaryjna 2016; 72:549–557. https://doi.org/10.21521/mw.5562

Alcigir ME, Timurkan MO. The association between insulin- like growth factors I, II and bovine papillomavirus type-1 expressions in naturally occuring bovine fibropapilloma cases. Ankara Üniversitesi Veteriner Fakültesi Dergisi 2018; (65) 2:115–122. https://dergipark.org.tr/en/download/article-file/644923

Atasever A, Cam Y, Atalay O. Bir sığır sürüsünde deri papillomatosis olguları. Ankara Üniversitesi Veteriner Fakültesi Dergisi 2005; 52:197–200. https://teav.ankara.edu.tr/xmlui/bitstream/handle/20.500.12575/59133/1810.pdf?sequence=1

Aydin H, Gelen V, Şengül E, Yildirim S. Immunological effects of autogenous vaccine administration in cattle with cutaneous papillomatosis. Acta Vet Eurasia 2020; 46, 98-103. https://doi: 10.5152/actavet.2020.20002

Dagalp SB, Dogan F, Farzani TA, Salar S, Bastan A. The genetic diversity of bovine papillomaviruses (BPV) from different papillomatosis cases in dairy cows in Turkey. Arch Virol 2017; 162:1507–1518. https://doi.org/10.1007/s00705-017-3258-8

Dal Pozzo F, Thiry E. Antiviral chemotherapy in veterinary medicine: current applications and perspectives. Rev Sci Tech 2014; 33(3):791–797. https://doi.org/10.20506/rst.33.3.2318

Daudt C, Da Silva FR, Lunardi M, Alves CB, Weber MN, Cibulski SP, Canal CW. Papillomaviruses in ruminants: An update. Transbound Emerg Dis 2018; 65(5):1381–1395. https://doi.org/10.1111/tbed.12868

Doğan E, Erdağ D, Doğan AN, Kiliçle PA, Doğan A. Treatment of bovine skin papillomatosis with gasoline. Pak Vet J 2021; 41(1): 169-172. http://dx.doi.org/10.29261/pakvetj/2020.069

Fernandes KP, Alfieri AA, Darold GM, Boabaid FM, Agnol AM, Lunardi M. Case report: Mixed infection of bovine papillomaviruses associated with squamous papilloma of the upper alimentary tract in a dairy cow. Front Vet Sci 2022; 9:1020166. https://doi.org/10.3389/fvets.2022.1020166

Khattab MS, Ali AM, Osman AH, AbuBakr HO, Azouz RA, Ramadan ES, Farag HS. Bovine papillomatosis: A serological, hematobiochemical, ultrastructural and immunohistochemical investigation in cattle. Pakistan Vet J 2023; 43(2). https://doi.org/10.29261/pakvetj/2023.023

Knight CG. The association between equine Papillomavirus type 2 and equine Squamous cell carcinomas: a thesis presented in partial fulfilment of the requirements for the degree of Doctor of Philosophy in Veterinary Science at Massey University, Palmerston North, New Zealand. Doctoral dissertation, Massey University; 2015. http://hdl.handle.net/10179/9863

Lacey CJ, Thompson HS, Monteiro EF, O'neill T, Davies ML, Holding FP, Roberts JS. Phase IIa safety and immunogenicity of a therapeutic vaccine, TA-GW, in persons with genital warts. J Infect Dis 1999; 179(3):612–618. https://doi.org/10.1086/314616

Marć MA, Domínguez-Álvarez E, Gamazo C. Nucleic acid vaccination strategies against infectious diseases. Expert Opin Drug Del 2015; 12(12):1851–1865. https://doi.org/10.1517/17425247.2015.1077559

Méndez I, Muñoz FA, González M, Martínez AY, Hernández LE. Características histopatológicas y detección de Papilomavirus en la fibropapilomatosis bovina en el estado de San Luis Potosí, México. Rev Mex Cienc Pecu 2021; 12(1):286–297. https://doi.org/10.22319/rmcp.v12i1.5999

Pathania S, Kumar P, Devi LG, Kumar D, Dhama K, Somvanshi R. Preliminary assessment of binary ethylenimine inactivated and saponized cutaneous warts (BPV-2) therapeutic vaccine for enzootic bovine haematuria in hill cows. Vaccine 2011; 29(43):7296–7302. https://doi.org/10.1016/j.vaccine.2011.07.065

Ranjan R, Ghumman SP, Bhath GR, Singh RS. Efficacy of autogenous vaccine and auto-hemotherapy in bovine cutaneous papillomatosis. Intas Polivet 2013; 14:411–415. Online ISSN: 2249–8796. https://www.entomoljournal.com/archives/2020/vol8issue5/PartL/8-5-280-291.pdf

Saied AA, Metwally AA, Mohamed HM, Haridy MA. The contribution of bovines to human health against viral infections. Environ. Sci. Pollut 2021; 28(34), 46999-47023. https://doi.org/10.1007/s11356-021-14941-z

Saied AA. Regression of bovine cutaneous papillomas via ivermectin-induced immunostimulant and oxidative stress. J. Adv. Vet. Anim 2021; 8(3), 370. https://doi.org/10.5455/javar.2021.h525

Salib FA, Farghali HA. Clinical, epidemiological and therapeutic studies on Bovine Papillomatosis in Northern Oases, Egypt in 2008. Vet World 2011; 4(2):53–59. http://dx.doi.org/10.5455/vetworld.2011.53-59

Skeate JG, Woodham AW, Einstein MH, Da Silva DM, Kast WM. Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases. Hum Vaccines Immunother 2016; 12(6):1418–1429. https://doi.org/10.1080/21645515.2015.1136039

Tozato CC, Lunardi M, Alfieri AF, Otonel RAA, Di Santis GW, de Alcântara BK, Headley SA, Alfieri AA. Teat papillomatosis associated with bovine papillomavirus types 6, 7, 9, and 10 in dairy cattle from Brazil. Braz J Microbiol 2013; 44 (3). https://doi.org/10.1590/S1517-83822013005000057

Ugochukwu IC, Aneke CI, Idoko IS, Sani A, Amoche AJ, Mshiela WP, Ede RE, Ibrahim ND, Njoku CI, Sackey AK. Bovine papilloma: aetiology, pathology, immunology, disease status, diagnosis, control, prevention and treatment: a review. Comp Clin Pathol 2019; 28, 737–745. https://doi.org/10.1007/s00580-018-2785-3

Yildirim Y, Küçük A, Kale M, Hasircioğlu S, Atli K, Saltik HS. Evaluating the Efficiency of Various Treatment Methods in Cattle Cutaneous Papillomatosis. Vet It 2023; 59(4). https://doi.org/10.12834/VetIt.3138.21450.2

Downloads

Published

2025-03-14

How to Cite

Suárez-Usbeck, A., Vinueza, P., Mora, M., Carrasco, A., Echeverria, T., & Vela, A. (2025). Immunological effects of autohemo vaccination and autogenous vaccination in bovine with cutaneous papillomatosis virus. Revista Colombiana De Ciencias Pecuarias. https://doi.org/10.17533/udea.rccp.e355957

Issue

Section

Accepted manuscripts